Cardiovascular and metabolic effects of the vasopeptidase inhibitor, omapatrilat in spontaneously hypertensive rats

被引：0
|
作者：
Ginoza, M [1 ]
Marques, A [1 ]
Cesaretti, M [1 ]
Zanella, M [1 ]
Ribeiro, A [1 ]
Kohlmann, O [1 ]
机构：
[1] Univ Fed Sao Paulo, Kidney & Hypertens Hosp, Div Nephrol, Sao Paulo, Brazil
来源：
JOURNAL OF HYPERTENSION | 2000年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S63 / S63
页数：1
相关论文
共 50 条
  • [1] Cardiovascular and metabolic effects of the vasopeptidase inhibitor, omapatrilat, in spontaneously hypertensive rats
    Ginoza, M
    Marques, AG
    Cesaretti, MLR
    Neves, CRS
    Pereira, AS
    Kohlmann, NEB
    Tavares, A
    Zanella, MT
    Ribeiro, AB
    Kohlmann, O
    JOURNAL OF HYPERTENSION, 2004, 22 : S187 - S187
  • [2] The antihypertensive and antihypertrophic effects of the vasopeptidase inhibitor omapatrilat in spontaneously hypertensive rats
    Wei, CM
    Dong, YF
    Zhou, H
    Shaffer, E
    Liao, WC
    McLaughlin, JS
    FASEB JOURNAL, 2001, 15 (04): : A466 - A466
  • [3] The cardiovascular actions of omapatrilat in spontaneously hypertensive rats
    Dong Y.
    Zhou H.
    Shaffer E.
    Atamas N.
    Liao W.-C.
    Wei C.
    Current Hypertension Reports, 2001, 3 (Suppl 2) : s1 - s5
  • [4] Beneficial and adverse renal and vascular effects of the vasopeptidase inhibitor omapatrilat in renovascular hypertensive rats
    Wenzel, UO
    Wolf, G
    Jacob, I
    Schwegler, C
    Qasqas, A
    Amann, K
    Helmchen, U
    Stahl, RAK
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (10) : 2005 - 2013
  • [5] Role of bradykinin in the cardiovascular effects of omapatrilat in spontaneously hypertensive rats (SHR)
    Marques, AG
    Cesaretti, ML
    Ginoza, M
    Ribeiro, AB
    Kohlmann, O
    AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (05) : 175A - 175A
  • [6] The actions of omapatrilat, vasopeptidase inhibitor (VPI), on cardiac hypertrophy and brain natriuretic peptide (BNP) concentration in spontaneously hypertensive rats
    Wei, CM
    Dong, YF
    Lin, RX
    FASEB JOURNAL, 2002, 16 (05): : A928 - A928
  • [7] Attenuation of cardiovascular remodeling in DOCA-salt rats by the vasopeptidase inhibitor, omapatrilat
    Loch, David
    Hoey, Andrew
    Brown, Lindsay
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2006, 28 (05) : 475 - 488
  • [8] Cardiac and renal effects of omapatrilat, a vasopeptidase inhibitor, in rats with experimental congestive heart failure
    Abassi, ZA
    Yahia, A
    Zeid, S
    Karram, T
    Golomb, E
    Winaver, J
    Hoffman, A
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2005, 288 (02): : H722 - H728
  • [9] Cardiac and renal effects of omapatrilat, a vasopeptidase inhibitor, in rats with heart failure: Comparison with enalapril
    Abassi, ZA
    Zeid, S
    Yahia, A
    Winaver, J
    Hoffman, A
    AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (05) : 84A - 84A
  • [10] Role of bradykinin on the effects of vasopeptidase inhibition in spontaneously hypertensive rats (SHR)
    Marques, AG
    Cesaretti, MLR
    Ginoza, M
    Neves, CRS
    Kohlmann, NEB
    Tavares, A
    Zanella, MT
    Ribeiro, AB
    Kohlmann, O
    JOURNAL OF HYPERTENSION, 2004, 22 : S175 - S175
12345